Transient Central Diabetes Insipidus after Discontinuation of Vasopressin
Joint Authors
Carman, Nathaniel
Kay, Carl
Petersen, Abigail
Kravchenko, Maria
Tate, Joshua
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-12-11
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Central diabetes insipidus (CDI) is an uncommon condition resulting from lack of vasopressin secretion from the posterior pituitary gland typically caused by some form of destruction of the gland.
Here we present a case of transient CDI after discontinuation of vasopressin used for septic shock without evidence of overt pituitary damage.
Serum sodium concentration peaked at 160 mmol/L in the setting of polyuria within days of vasopressin discontinuation without identified alternative etiologies.
Sodium levels and urine output normalized with administration of desmopressin with continued stability after desmopressin was discontinued.
This is one of few reported cases of diabetes insipidus occurring after discontinuation of vasopressin and the rapid and profound response to desmopressin in this case proves a central etiology.
This case allows for speculation into predisposing risk factors for this phenomenon including preexisting neurological disease.
American Psychological Association (APA)
Carman, Nathaniel& Kay, Carl& Petersen, Abigail& Kravchenko, Maria& Tate, Joshua. 2019. Transient Central Diabetes Insipidus after Discontinuation of Vasopressin. Case Reports in Endocrinology،Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1135728
Modern Language Association (MLA)
Carman, Nathaniel…[et al.]. Transient Central Diabetes Insipidus after Discontinuation of Vasopressin. Case Reports in Endocrinology No. 2019 (2019), pp.1-4.
https://search.emarefa.net/detail/BIM-1135728
American Medical Association (AMA)
Carman, Nathaniel& Kay, Carl& Petersen, Abigail& Kravchenko, Maria& Tate, Joshua. Transient Central Diabetes Insipidus after Discontinuation of Vasopressin. Case Reports in Endocrinology. 2019. Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1135728
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1135728